What diseases does Lamivudine Dolutegravir tablets treat?

Lamivudine Dolutegravir Tablets(Dolutegravir) is a fixed combination antiretroviral drug containing dolutegravir and lamivudine. Lamivudine Dolutegravir Tablets Treats HIV (HIV-1) infection in antiretroviral therapy-naive (previously untreated) adults who have no known alternative drugs associated with dolutegravir or lamivudine resistance.

DetectHBV virus infection before starting to takelamivudine dolutegravir tablets. Take a pregnancy test before a woman of childbearing potential starts taking lamivudine dolutegravir. Adults who have not received antiretroviral therapy: 1 tablet once daily (dolutegravir 50 mg and lamivudine 300 mg). Antiretroviral-naïve adults receiving carbamazepine or rifampicin, 1 tablet (50mgdolutegravir and 300mg lamivudine) and 50 single-entity dolotegravir tablets taken once daily 12 hours after taking the fixed combination tablet. It is recommended that women of childbearing potential continue to use effective contraceptive methods during treatment with lamivudine dolutegravir tablets. If a woman is currently being treated with lamivudine dolutegravir and is actively trying to become pregnant, or if pregnancy is confirmed early in pregnancy, inform the woman of the potential risks to the embryo from exposure to lamivudine dolutegravir from the time of conception through the first trimester. Assess the risks and benefits of continuing versus switching to a different antiretroviral regimen and consider switching to a regimen that does not contain dolutegravir. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0